Ki-67 Expression in CRC Lymph Node Metastasis Does Not Predict Survival

Table 3

Assessment of correlation between Ki-67 expression and clinical data.

	Ki-67 in CRC			Ki-67 in lymph node metastasis
		Positive (%)			Positive (%)
Gender
Male	307	212 (69.1)	0.675	71	41 (57.7)	0.438
Female	180	121 (67.2)		38	19 (50.0)
Age
≤45	23	14 (60.9)	0.491	7	4 (57.1)	1.000^*
>45	464	319 (68.8)		102	56 (54.9)
Presentation
Asymptomatic	88	63 (71.6)	0.474	19	8 (42.1)	0.212
Symptomatic	399	270 (67.7)		90	52 (57.8)
Localization
Colon	353	240 (68.0)	0.764	90	50 (55.5)	0.841
Rectum	134	93 (69.4)		19	10 (52.6)
Macroscopic cancer type
Polypoid	253	171 (67.6)	0.178	45	20 (44.4)	0.373
Ulcerative	111	76 (68.5)		31	20 (64.5)
Infiltrative	38	22 (57.9)		11	6 (54.5)
Exophytic	39	32 (82.1)		12	7 (58.3)
Vilosous	2	2 (100.0)		1	0 (0)
CEA (ng/mL)
≤10	337	229 (68.0)	0.750	67	34 (50.7)	0.757
>10	73	51 (69.1)		22	12 (54.5)

Comparisons were examined for statistical significance using Fisher’s exact test (when < 5).